Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Trulieve Cannabis (TCNNF) Treasury Shares (2020 - 2026)

Trulieve Cannabis has reported Treasury Shares over the past 6 years, most recently at $5.8 million for Q4 2025.

  • For Q4 2025, Treasury Shares rose 83.35% year-over-year to $5.8 million; the TTM value through Dec 2025 reached $5.8 million, up 83.35%, while the annual FY2025 figure was $5.8 million, 83.35% up from the prior year.
  • Treasury Shares for Q4 2025 was $5.8 million at Trulieve Cannabis, down from $8.3 million in the prior quarter.
  • Over five years, Treasury Shares peaked at $8.3 million in Q3 2025 and troughed at $332428.0 in Q4 2021.
  • A 5-year average of $3.5 million and a median of $3.2 million in 2023 define the central range for Treasury Shares.
  • Biggest five-year swings in Treasury Shares: crashed 94.52% in 2021 and later skyrocketed 658.87% in 2024.
  • Year by year, Treasury Shares stood at $332428.0 in 2021, then skyrocketed by 116.8% to $720707.0 in 2022, then soared by 272.72% to $2.7 million in 2023, then increased by 18.37% to $3.2 million in 2024, then skyrocketed by 83.35% to $5.8 million in 2025.
  • Business Quant data shows Treasury Shares for TCNNF at $5.8 million in Q4 2025, $8.3 million in Q3 2025, and $7.5 million in Q2 2025.